NIH-funded research NIH-funded research

Investigating how a protein affects kidney injury and metabolism

Official title: The role of transcriptional corepressor CtBP2 as a metabolic sensor in acute kidney injury

Funded at Ohio State University · NIH-11174187 · Data updated 2026-11-12

This study is looking at how a protein called CtBP2 affects kidney damage in people with acute kidney injury (AKI) and aims to find new ways to protect kidney function by understanding how energy changes in the body contribute to this condition.

More Acute Kidney Injury research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionOhio State University
NIH-funded
Lab location1 site (Columbus, UNITED STATES)
Project startSeptember 17, 2024
Project endSeptember 16, 2025
Funding year2024
Award (this year)$199,990
NIH project number1R56DK140315-01
Project IDNIH-11174187 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are hospitalized patients at risk of acute kidney injury, particularly those with conditions that may lead to kidney stress.

Less likely to help

Patients with stable kidney function and no history of acute kidney injury are unlikely to benefit from this research.

What this research studies

This research focuses on understanding the role of a protein called CtBP2 in acute kidney injury (AKI), a serious condition that can occur in hospitalized patients. The study aims to explore how changes in energy metabolism, specifically involving a molecule called NAD+, contribute to kidney damage during AKI. By examining the effects of inhibiting CtBP2 in various models of kidney injury, the researchers hope to identify new therapeutic strategies that could protect kidney function and improve patient outcomes. This work involves advanced techniques like ChIP-seq to analyze gene expression related to kidney health.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that prevent or mitigate acute kidney injury, ultimately improving recovery and reducing the risk of chronic kidney disease.

How similar studies have gone: Previous research has shown promising results in targeting metabolic pathways in kidney injury, suggesting that this approach may yield significant insights and advancements.

Where this research is happening

  • Ohio State University
    Columbus, United States
    Active

Researchers

  • Principal investigator: Kim, Jiyoung — Ohio State University
  • Study coordinator: Kim, Jiyoung

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.